These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20645061)

  • 1. The use of hepatocytes to investigate drug uptake transporters.
    Maeda K; Sugiyama Y
    Methods Mol Biol; 2010; 640():327-53. PubMed ID: 20645061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of solute carrier (SLC) drug uptake transporter loss in human and rat cryopreserved hepatocytes on clearance predictions.
    Lundquist P; Lööf J; Sohlenius-Sternbeck AK; Floby E; Johansson J; Bylund J; Hoogstraate J; Afzelius L; Andersson TB
    Drug Metab Dispos; 2014 Mar; 42(3):469-80. PubMed ID: 24396146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes.
    De Bruyn T; Ye ZW; Peeters A; Sahi J; Baes M; Augustijns PF; Annaert PP
    Eur J Pharm Sci; 2011 Jul; 43(4):297-307. PubMed ID: 21605667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of digoxin uptake in sandwich-cultured human hepatocytes.
    Kimoto E; Chupka J; Xiao Y; Bi YA; Duignan DB
    Drug Metab Dispos; 2011 Jan; 39(1):47-53. PubMed ID: 20926619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic uptake in the dog: comparison of uptake in hepatocytes and human embryonic kidney cells expressing dog organic anion-transporting polypeptide 1B4.
    Wilby AJ; Maeda K; Courtney PF; Debori Y; Webborn PJ; Kitamura Y; Kusuhara H; Riley RJ; Sugiyama Y
    Drug Metab Dispos; 2011 Dec; 39(12):2361-9. PubMed ID: 21940906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting carrier-mediated hepatic disposition of rosuvastatin in man by scaling from individual transfected cell-lines in vitro using absolute transporter protein quantification and PBPK modeling.
    Bosgra S; van de Steeg E; Vlaming ML; Verhoeckx KC; Huisman MT; Verwei M; Wortelboer HM
    Eur J Pharm Sci; 2014 Dec; 65():156-66. PubMed ID: 25261337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of hepatocytes to assess the contribution of hepatic uptake to clearance in vivo.
    Soars MG; Grime K; Sproston JL; Webborn PJ; Riley RJ
    Drug Metab Dispos; 2007 Jun; 35(6):859-65. PubMed ID: 17344337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uptake and efflux transporters for conjugates in human hepatocytes.
    Keppler D
    Methods Enzymol; 2005; 400():531-42. PubMed ID: 16399368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of transporter-mediated hepatic uptake in a non-radioactive high-throughput assay: a study of kinetics, species difference and plasma protein effect.
    Li L; Nouraldeen A; Wilson AG
    Xenobiotica; 2013 Mar; 43(3):253-62. PubMed ID: 22928802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transporters as a determinant of drug clearance and tissue distribution.
    Shitara Y; Horie T; Sugiyama Y
    Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the overall renal tubular secretion and hepatic clearance of anionic drugs and a renal drug-drug interaction involving organic anion transporter 3 in humans by in vitro uptake experiments.
    Watanabe T; Kusuhara H; Watanabe T; Debori Y; Maeda K; Kondo T; Nakayama H; Horita S; Ogilvie BW; Parkinson A; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2011 Jun; 39(6):1031-8. PubMed ID: 21383204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting inhibition of the transporter-mediated hepatic uptake of sulfobromophthalein by cyclosporin a in rats.
    Shitara Y; Nagamatsu Y; Wada S; Sugiyama Y; Horie T
    Drug Metab Dispos; 2009 Jun; 37(6):1172-8. PubMed ID: 19282398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
    Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
    Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the hepatic and renal clearance of transporter substrates in rats using in vitro uptake experiments.
    Watanabe T; Maeda K; Kondo T; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2009 Jul; 37(7):1471-9. PubMed ID: 19364828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and hepatic uptake of eltrombopag, a novel platelet-increasing agent.
    Takeuchi K; Sugiura T; Umeda S; Matsubara K; Horikawa M; Nakamichi N; Silver DL; Ishiwata N; Kato Y
    Drug Metab Dispos; 2011 Jun; 39(6):1088-96. PubMed ID: 21422191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
    Ho RH; Tirona RG; Leake BF; Glaeser H; Lee W; Lemke CJ; Wang Y; Kim RB
    Gastroenterology; 2006 May; 130(6):1793-806. PubMed ID: 16697742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes.
    Kotani N; Maeda K; Watanabe T; Hiramatsu M; Gong LK; Bi YA; Takezawa T; Kusuhara H; Sugiyama Y
    Drug Metab Dispos; 2011 Sep; 39(9):1503-10. PubMed ID: 21673128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitavastatin as an in vivo probe for studying hepatic organic anion transporting polypeptide-mediated drug-drug interactions in cynomolgus monkeys.
    Takahashi T; Ohtsuka T; Yoshikawa T; Tatekawa I; Uno Y; Utoh M; Yamazaki H; Kume T
    Drug Metab Dispos; 2013 Oct; 41(10):1875-82. PubMed ID: 23929936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the rate-determining process in the hepatic elimination of HMG-CoA reductase inhibitors in rats and humans.
    Watanabe T; Kusuhara H; Maeda K; Kanamaru H; Saito Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2010 Feb; 38(2):215-22. PubMed ID: 19875501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of the OATP hepatic uptake transport protein family in DMPK sciences: from obscure liver transporters to key determinants of hepatobiliary clearance.
    Fenner KS; Jones HM; Ullah M; Kempshall S; Dickins M; Lai Y; Morgan P; Barton HA
    Xenobiotica; 2012 Jan; 42(1):28-45. PubMed ID: 22077101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.